Cited by 526Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsAcute Ischemic Stroke Management

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, Katherine S., Liang, Matthew H., Newcomer, Laura, Goldhaber, Samuel Z., Schur, Peter H., Hennekens, Charles H., Stampfer, Meir J.·1992·Annals of Internal Medicine

DOI 10.7326/0003-4819-117-12-997

Open this paper in CoChat — free account

Abstract

Objective To determine whether the presence of anticardiolipin antibodies is a risk factor for ischemic stroke and venous thrombosis in healthy adult men. Design A nested, case-control study in a prospective cohort. Setting A nationwide study of physicians. Participants The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22,071 male physicians. At entry, 68% of the participants submitted plasma samples that were subsequently frozen at -80 degrees C. During 60.2 months of follow-up, follow-up for nonfatal outcomes was 99.7% complete and ascertainment of fatal outcomes was 100% complete. We identified men with documented ischemic stroke, deep venous thrombosis of the leg, or pulmonary embolus and for whom a plasma sample was available. A control was matched by age, smoking history, and length of follow-up to each of the 100 patients with ischemic stroke and the 90 patients with deep venous thrombosis or pulmonary embolus. Measurements Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay. The mean anticardiolipin antibody titers of the case patients in the two diagnostic groups (ischemic stroke; venous thrombosis or pulmonary embolus) were compared with those of the control groups, and relative risks were calculated for patients in increasing percentile categories of anticardiolipin antibodies by conditional logistic regression. Results T…

Integrity signals

Registry

Crossref · 10.7326/0003-4819-117-12-997

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATION
Carreras, L., Machin, S. J., Deman, R., DEFREYN, G., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
The Steering Committee of the Physicians' Health Study Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180431 · Cited by 522

Show all 49 references

Research works printed but not linked: 15

Meyer O, 1987, J Rheum., 14, 502
Colaco C, 1983, Ann Rheum Dis., 42, 228
Harris E, 1985, J Clin Lab Immunol., 16, 1
Colaco C, 1985, Clin Exp Immunol., 59, 449
Harris E, 1987, Clin Exp Immunol., 68, 215
Hall S, 1984, J Rheum., 11, 846
Asherson R, 1989, Q J Med., 73, 1103
Cronin M, 1988, J Rheum., 15, 795
Klemp P, 1988, Clin Exp Immunol., 74, 254
Lavalle C, 1990, J Rheum., 17, 34
Coon W, 1976, Surg Gynecol Obstet., 143, 385
Hasselaar P, 1990, J Rheumatol., 17, 186
Loizou S, 1985, Clin Exp Immunol., 62, 738
Ruiz-Arguelles G, 1989, J Rheumatol., 16, 381
McNeil H, 1990, Clin Exp Rheumatol., 8, 525

Sorted by citations

Items 301–400 of 525

Antioxidants and female reproductive pathologies
Gupta, S., Surti, N., Metterle, L., Chandra, A., & Agarwal, A. K. (2009) · Cited by 12
Antiphospholipid antibodies in critical illness
Dentali, F., & Crowther, M. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9e363 · Cited by 11
Mitral valve prolapse in young healthy individuals. An early index of autoimmunity?
Evangelopoulos, M., Toumanidis, S. T., Sotou, D., Evangelopoulos, C. D., Mavrikakis, M., Alevizaki, M., & Dimopoulos, M. A. (2009) · Lupus · doi:10.1177/0961203308098598 · Cited by 11
Treatment of the antiphospholipid syndrome
Pietté, J. C., Karmochkine, M., Papo, T., Du-Boutin, L. T. H., Francès, C., & Wechsler, B. (1995) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02772251 · Cited by 11
Acquired Thrombophilia during Pregnancy
Dentali, F., & Crowther, M. A. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2006.05.006 · Cited by 11
Systemic Lupus Erythematosus
Petri, M., Aringer, M., Ayoub, I. M., Almaani, S. J., Brunner, H. I., Dall’Era, M., Jiang, M., Furie, R. A., Greco, J. M., Goldblatt, F., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_12 · Cited by 12
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients
Caso, V., Parnetti, L., Panarelli, P., Magni, M. V., Gallai, V., & Albi, E. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1045-9 · Cited by 10
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive
Giles, I., & Rahman, A. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.01.009 · Cited by 11
Screening for coagulation disorders in patients with ischemic stroke
de Lau, L. M. L., Leebeek, F. W. G., de Maat, M. P. M., Koudstaal, P. J., & Dippel, D. W. J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.104 · Cited by 10
Evidence-based management of thrombosis in the antiphospholipid antibody syndrome
Petri, M. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0023-7 · Cited by 11
Facteurs de risque et incidence de la maladie thromboembolique veineuse en médecine interne : une étude descriptive prospective sur 947 patients hospitalisés
Pottier, P., Planchon, B., Pistorius, M.-A., & Grolleau, J. Y. (2001) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(01)00347-2 · Cited by 10
Drug-Induced Antiphospholipid Antibodies
Sammaritano, L. R. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_15 · Cited by 10
Antiphospholipid Syndrome in Childhood: The Great Unknown
Tucker, L. B. (1994) · Lupus · doi:10.1177/096120339400300502 · Cited by 10
Clinical research in systemic lupus erythematosus: immediate relevance to clinical practice
Petri, M. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2010.01590.x · Cited by 9
Antiphospholipid antibodies in young women with and without oral contraceptive use
Vad, S., Lakos, G., Kiss, E. V., Sipka, S., Csorba, R., & Póka, R. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200301000-00010 · Cited by 9
The antiphospholipid antibody syndrome
Nimmo, M., & Carter, C. J. (2003) · Clinical and Applied Immunology Reviews · doi:10.1016/s1529-1049(03)00047-3 · Cited by 8
Anticardiolipin antibodies are associated with cognitive dysfunction in stroke‐free individuals
Homayoon, N., Schwingenschuh, P., Hofer, E., Katschnig, P., & Schmidt, R. (2013) · European Journal of Neurology · doi:10.1111/ene.12316 · Cited by 9
Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus
Oger, E., Leroyer, C., Dueymes, M., Moigne, E. L., Bressolette, L., Escoffre‐Barbe, M., Youinou, P., & Mottier, D. (1997) · Lupus · doi:10.1177/096120339700600508 · Cited by 9
Anticardiolipin antibodies in children with insulin-dependent diabetes mellitus
Mohamed, S. M., Abdou, M. O., Assem, H. M., Moustafa, T. M., & Soghier, L. M. (2002) · Metabolism · doi:10.1053/meta.2002.34705 · Cited by 9
Case 18-1999
Rennke, H. G., & Laposata, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402408 · Cited by 9
Cerebral Disease in the Antiphospholipid Syndrome
Navarrete, M. G., Brey, R. L., & Levine, S. R. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_5 · Cited by 9
Cerebrovascular Disease in Infants and Children
Zimmerman, R. A., & Bilaniuk, L. T. (2005) · Springer eBooks · doi:10.1007/3-540-26398-5_7 · Cited by 9
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch
Hasbani, G. E., & Uthman, I. W. (2023) · Lupus · doi:10.1177/09612033231165151 · Cited by 10
Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety
Qushmaq, N. A., & Al-Emadi, S. A. (2014) · ISRN Rheumatology · doi:10.1155/2014/348726 · Cited by 8
Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women
Todorova, M., Kamenov, Z. A., Baleva, M. P., Christov, V. G., & Nicolov, K. (2004) · Maturitas · doi:10.1016/j.maturitas.2003.10.009 · Cited by 8
Neurologic Manifestations in the Antiphospholipid Syndrome
Brey, R. L., Levine, S. R., & Stallworth, C. L. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50019-x · Cited by 8
Controversies in the antiphospholipid syndrome and stroke
Gatenby, P. A. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.033 · Cited by 8
Total Occlusion of Inferior Vena Cava in a Patient With Antiphospholipid Antibody Syndrome Associated With Behcet's Disease.
Mukai, Y., Tsutsui, H., Todaka, K., Mohri, M., Hirai, N., Arai, H., & Takeshita, A. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.837 · Cited by 8
Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (hughes syndrome)
Cuadrado, M. J. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0083-0 · Cited by 8
Acute Neurolupus Manifested by Seizures Is Associated with High Frequency of Abnormal Cerebral Blood Flow Velocities
Baizabal‐Carvallo, J. F., Cantú-Brito, C. G., & García-Ramos, G. S. (2008) · Cerebrovascular Diseases · doi:10.1159/000118381 · Cited by 8
Hypercoagulability and the hypercoagulability syndromes.
Perler, B. A. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.164.3.7863872 · Cited by 8
Stroke Risk Factors
Tuhrim, S. (2000) · CNS Spectrums · doi:10.1017/s1092852900012980 · Cited by 8
Antiphospholipid Syndrome
Levine, S. R., & Erkan, D. (2004) · Technical report · doi:10.1016/s1571-5078(04)03004-1 · Cited by 8
Pulmonary Hypertension and Antiphospholipid Antibodies
Pietté, J. C., & Hunt, B. J. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_10 · Cited by 8
The Antiphospholipid Syndrome and Pregnancy: Invited Review
Arnout, J., Spitz, B., Vanassche, A., & Vermylen, J. (1995) · Hypertension in Pregnancy · doi:10.3109/10641959509009577 · Cited by 8
Estrategias terapéuticas en el síndrome antifosfolipídico
Cervera, R. (2009) · Reumatología Clínica · doi:10.1016/j.reuma.2008.11.020 · Cited by 8
Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
Ducloux, D., Pellet, E., & Chalopin, J. M. (1997) · Transplantation Proceedings · doi:10.1016/s0041-1345(97)00419-3 · Cited by 7
Carbamazepine-induced thrombocytopenia defined by a challenge test
Ishikita, T., Ishiguro, A., Fujisawa, K., Tsukimoto, I., & Shimbo, T. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199909)62:1 · Cited by 17
Persistency of low levels of anticardiolipin and anti-Beta2 Glycoprotein1 in thrombosis
Amaral, M., Favas, C., & Alves, J. D. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.12.010 · Cited by 7
Antiphospholipid syndrome: Unusual clinical presentations
Greaves, M. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70013-5 · Cited by 7
Antiphospholipid (Hughes) Syndrome: An Overview
D’Cruz, D. P. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_2 · Cited by 7
Lupus anticoagulants in children
Briones, M. A., & Abshire, T. C. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200309000-00009 · Cited by 7
Venous Thromboembolism in Abdominoplasty Patients: A Study of Incidence and Prophylaxis Recommendations
Pancholi, S., & Cuzalina, A. L. (2007) · The American Journal of Cosmetic Surgery · doi:10.1177/074880680702400203 · Cited by 7
Systemic Lupus Erythematosus
Lahita, R. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00032-0 · Cited by 7
Antiphospholipid syndrome
Khamashta, M. A., & Amigo, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00139-x · Cited by 8
Antiphospholipid Syndrome: A Series of Surgical Emergencies and the Current Evidence for its Management
Agaba, A., Charaklias, N., Babu-Victor, A., Agaba, P., Deepchand, V., Dabasia, H., Ss, S., Goodrick, M. A., & Ramanand, B. (2006) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588406x106496 · Cited by 8
Central vein thrombosis in the antiphospholipid syndrome
Alcázar-Ramírez, J., Femández-Nebro, A., Abarca, M., Salgado, F., Liger, M. H., Rodríguez-Andréu, J., & González‐Santos, P. (1997) · Lupus · doi:10.1177/096120339700600614 · Cited by 7
Antiphospholipid antibody syndrome
Cucurull, E., Gharavi, A. E., Menon, Y., & Wilson, W. A. (2003) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-003-0021-0 · Cited by 7
Phospholipid Autoantibodies — Cardiolipin
Khamashta, M. A., & Hughes, G. R. V. (1996) · Elsevier eBooks · doi:10.1016/b978-044482383-0/50095-9 · Cited by 7
Thrombosis and antiphospholipid antibodies ‐ an evolving story
Ryan, P. F. J., & Street, A. (1993) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1993.tb01808.x · Cited by 7
Syndrome des antiphospholipides
Blétry, O., Piette, A. M., & Dray, J. (1997) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(97)80142-4 · Cited by 7
The Antiphospholipid Syndrome
Breen, K. A. (2017) · Wiley eBooks · doi:10.1002/9781119095606.ch8 · Cited by 7
Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus
Al-Ewaidat, O. A., & Naffaa, M. M. (2024) · Medicines · doi:10.3390/medicines11070015 · Cited by 7
Stratégie diagnostique et intérêt comparatif des scores cliniques pour le diagnostic d’embolie pulmonaire
Blondon, M., Gal, G. L., & Righini, M. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.07.012 · Cited by 6
The importance of measuring anticardiolipin antibodies
de Groot, P. G., & Derksen, R. H. W. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01689.x · Cited by 6
Pathogenesis and management of antiphospholipid syndrome
Greaves, M. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70002-7 · Cited by 7
Therapeutic strategies in antiphospholipid syndrome
Cervera, R. (2010) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(10)70007-1 · Cited by 6
Audit of laboratory investigation of antiphospholipid syndrome
Myers, B., Dolan, G., & Gould, J. C. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.0115_1cr.x · Cited by 6
Anticuerpos antifosfolípido en población pediátrica asintomática
Franco, C., & Cuesta, J. (2001) · Anales de Pediatría · doi:10.1016/s1695-4033(01)77566-2 · Cited by 6
Antiphospholipid antibodies and stroke
Tuhrim, S. (2004) · Current Cardiology Reports · doi:10.1007/s11886-004-0011-1 · Cited by 6
Prolonged Activated Partial Thromboplastin Time In Pregnancy: A Brief Report
Russo, L. A., Bernstein, A., Sheth, M. V., Patel, D. V., Ahmed, S., Siddiqui, A. K., & Bhargava, A. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200403000-00003 · Cited by 6
Síndrome do anticorpo antifosfolípide
Louzada, P., Simon, S. M., Voltarelli, J. C., & Eduardo, D. (1998) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v31i2p305-315 · Cited by 6
Thoracic Imaging Features of Patients with Antiphospholipid Antibodies
Gilkeson, R., Patz, E. F., Culhane, D. K., McAdams, H. P., & Provenzale, J. M. (1998) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199803000-00015 · Cited by 6
Quels critères pour le diagnostic du syndrome des antiphospholipides?
Pietté, J. C., Wechsler, B., Blétry, O., & Godeau, P. (1993) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)81428-6 · Cited by 6
Lupus anticoagulant: A potential risk factor for complication following percutaneous transluminal coronary angioplasty
Anglin, P., Strauss, B. H., Brandwein, J. M., & Watson, K. R. (1994) · Catheterization and Cardiovascular Diagnosis · doi:10.1002/ccd.1810310208 · Cited by 6
Prevalence of antiphospholipid antibodies in patients with sterility undergoing ‘in vitro’ fertilization
Proietta, M., Ferrero, S., & Porto, F. D. (2014) · Lupus · doi:10.1177/0961203314525865 · Cited by 6
Neurovascular Issues in Antiphospholipid Syndrome: Arterial Vasculopathy from Small to Large Vessels in a Neuroradiological Perspective
Zedde, M., Grisendi, I., Assenza, F., Napoli, M., Moratti, C., Bonacini, L., Cecco, G. D., D’Aniello, S., Pavone, C., Pezzella, F. R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133667 · Cited by 5
Antiphospholipid (Hughes) syndrome: a review with update
MALAVIYA, A. N. (2003) · APLAR Journal of Rheumatology · doi:10.1046/j.0219-0494.2003.00041.x · Cited by 5
Increased titer of anti-β2-glycoprotein I IgG antibody among factor V Leiden carriers during oral contraceptive use
Póka, R., Vad, S., Lakos, G., Bereczki, Z., Kiss, E. V., & Sipka, S. (2004) · Contraception · doi:10.1016/j.contraception.2003.08.016 · Cited by 5
Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing
Hood, D. B., Snyder, K. R., Buckner, T. R., HURLEY, B. L., Pitts, K. R., & Lopez, L. R. (2015) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2015.0012 · Cited by 5
The antiphospholipid syndrome
Barilaro, G., Espinosa, G., & Cervera, R. (2021) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2021.03.012 · Cited by 7
Systemic Lupus Erythematosus
Petri, M., Abuav, R., Boumpas, D. T., Goldblatt, F., Isenberg, D. A., Anhalt, G. J., Werth, V. P., & Looney, R. J. (2009) · Springer eBooks · doi:10.1007/978-1-84800-934-9_13 · Cited by 5
Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis
Tsai, M.-H., Tsai, W.-P., Liao, S.-T., & Liou, L.-B. (2003) · Lupus · doi:10.1191/0961203303lu459oa · Cited by 5
Hypercoagulability syndromes: what the dentist needs to know
Yepes, J. F., Sullivan, J. A., Castellanos, A. L., & Sollecito, T. P. (2007) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2006.11.023 · Cited by 5
Manifestations neurologiques du syndrome des antiphospholipides
Pietté, J. C., Amoura, Z., Wechsler, B., & Francès, C. (1998) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(98)80028-3 · Cited by 5
Antiphospholipid Antibody: Future Developments
Lockshin, M. D. (1994) · Lupus · doi:10.1177/096120339400300420 · Cited by 5
Definition and significance of high positivity aCL ELISA
Wahl, D. G., Devignes, J., Mohamed, S., Zuily, S., & Lecompte, T. (2012) · Lupus · doi:10.1177/0961203312443298 · Cited by 5
Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis
Willis, R., Cohen, H., Giles, I., Knight, J. S., Krilis, S. A., Rahman, A., & de Groot, P. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_5 · Cited by 5
Acute-Sinus Thrombosis in a Child with Antibodies against Cardiolipins
Söderman, M., Johnsson, H., Ericson, K., & Wallstedt, L. (1996) · Interventional Neuroradiology · doi:10.1177/159101999600200207 · Cited by 5
Management of Thrombosis in the Antiphospholipid Syndrome
Khamashta, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_39 · Cited by 5
Prevention of Primary Event
Orencia, A. J., & Biller, J. (1997) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30320-6 · Cited by 5
Relation between left ventricular and/or left atrial thrombus and anticardiolipin antibodies in patients with acute myocardial infarction
Güler, N., BİLGE, M., Eryonucu, B., Erkoç, R., & Sayarlıoğlu, M. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00780-3 · Cited by 4
HEMATOLOGY: COAGULATION PROBLEMS
Shapiro, S. S., & Spurgeon, S. E. F. (2004) · Elsevier eBooks · doi:10.1016/b978-012433901-9/50045-4 · Cited by 4
Risque thromboembolique veineux au cours des affections médicales aiguës. Partie 2 : situations à risque en milieu ambulatoire, en milieu médical hospitalier et en médecine interne
Jeune, S. L., Pistorius, M.-A., Planchon, B., & Pottier, P. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.01.023 · Cited by 4
Antiphospholipid antibodies and stroke†
SHANAHAN, J., & Ortel, T. L. (2002) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2002.124067 · Cited by 4
Antiphospholipid syndrome: why and how should we make the diagnosis?
Sibilia, J. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00014-9 · Cited by 4
Thrombotic Manifestations in the Antiphospholipid Syndrome
Ordi‐Ros, J., Selva-O’Callaghan, A., & Vilardell, M. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50018-8 · Cited by 4
Traitement des complications thrombotiques du syndrome des anticorps antiphospholipides : éclairages des essais thérapeutiques récents et zones d’ombre
Wahl, D. G., Perret‐Guillaume, C., & Pietté, J. C. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.05.013 · Cited by 4
Management of Thrombosis in Antiphospholipid Syndrome
Khamashta, M. A., & Ruiz‐Irastorza, G. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_43 · Cited by 4
The Association of HLA-DRB1 and DQB1 Alleles and a Study of Anticardiolipin Antibody and Anti-β2 Glycoprotein I Antibody in Korean SLE Patients
Lee, S. G., Cha, H., & Yang, Y. S. (2002) · Immune Network · doi:10.4110/in.2002.2.4.227 · Cited by 4
THE CLINICAL ASPECTS OF THE ANTIPHOSPHOLIPID SYNDROME
Khamashta, M. A., & Hughes, G. R. (2004) · Elsevier eBooks · doi:10.1016/b9-78-012433-9/01950-0430 · Cited by 4
The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management
Rand, J. H., Levin, M. B., & Alving, B. M. (2007) · Elsevier eBooks · doi:10.1016/b978-141602401-9.10019-7 · Cited by 4
Antiphospholipid syndrome
Erkan, D., & Lockshin, M. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10061-2 · Cited by 4
Antiphospholipid antibodies and the antiphospholipid syndrome
Harris, E. N., & Pierangeli, S. S. (1995) · Springer eBooks · doi:10.1007/978-3-642-79622-7_7 · Cited by 4
Antigenic specificities of ?antiphospholipid? autoantibodies
Roubey, R. A. S. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf00197518 · Cited by 4
Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis
Salem, H. (1996) · Lupus · doi:10.1177/096120339600500216 · Cited by 4
Anticardiolipin antibodies and cardiovascular disease.
Muir, K. W. (1995) · PubMed Central · Cited by 4
Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine
Santos, G. M., David, P., Hen, O., Ontiveros-Austria, J. L., Liran, R., Rodríguez‐Rodríguez, S., de Godói, J. C., Patt, Y. S., Beladev, S., Okazaki, E., et al. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.06.010 · Cited by 3
Should we be testing for antiphospholipid antibodies in unexplained pulmonary thromboembolism and atherosclerosis at autopsy?
Bierton, C., & Langlois, N. E. I. (2013) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-013-9412-z · Cited by 3
Neuropsychiatric Manifestations of Antiphospholipid Syndrome
Yelnik, C., Appenzeller, S., Sanna, G., Kozora, E., & Bertolaccini, M. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_10 · Cited by 3

Authors: Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Liang, Matthew H.
Goldhaber, Samuel Z.
Hennekens, Charles H.
Stampfer, Meir J.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1992-12-15
Volume: 117
Issue: 12
Pages: 997-1002
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-117-12-997
OpenAlex: W1491481195
Cited by: 526
References: 49
Citations by year: 2025: 2 · 2024: 7 · 2023: 5 · 2022: 1 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 15 · 2012: 16
FWCI: 16.25
Type: journal article
Language: en
Open access: closed
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA042182, CA 42182)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: anticardiolipin antibodies, ischemic stroke, venous thrombosis, deep vein thrombosis, pulmonary embolism, thrombophilia, risk factors, IgG, male physicians, Physicians' Health Study, aspirin, beta-carotene, anticoagulation, stroke prevention, antithrombotic therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Brain Ischemia, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Prospective Studies, Pulmonary Embolism, Risk Factors, Statistics as Topic, Thrombophlebitis, Case-Control Studies, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks